Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2572)
All Articles published online
|
Oct 28, 2007 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gabbay E, Zigmond E, Pappo O, Hemed N, Rowe M, Zabrecky G, Cohen R, Ilan Y. Antioxidant therapy for chronic hepatitis C after failure of interferon: Results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol 2007; 13(40): 5317-5323 [PMID: 17879400 DOI: 10.3748/wjg.v13.i40.5317] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i40/5317.htm |
| Number | Citing Articles |
| 1 |
Dalibor Černý, Nikolina Kutinová Canová, Jindřich Martínek, Aleš Hořínek, Eva Kmoníčková, Zdeněk Zídek, Hassan Farghali. Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: Involvement of inducible nitric oxide synthase and hemoxygenase-1. Nitric Oxide 2009; 20(1): 1 doi: 10.1016/j.niox.2008.08.006
|
| 2 |
V. Carreño. Review article: management of chronic hepatitis C in patients with contraindications to anti‐viral therapy. Alimentary Pharmacology & Therapeutics 2014; 39(2): 148 doi: 10.1111/apt.12562
|
| 3 |
Sha Li, Ning Wang, Yi-Gang Feng, Hong-Yun Li, Yibin Feng. Nutritional Antioxidant Therapies: Treatments and Perspectives. 2017; : 467 doi: 10.1007/978-3-319-67625-8_18
|
| 4 |
Zhenzhen Zhang, Liang Rong, Yi-Ping Li. Flaviviridae Viruses and Oxidative Stress: Implications for Viral Pathogenesis. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/1409582
|
| 5 |
Diana L. Diesen, Paul C. Kuo. Nitric Oxide and Redox Regulation in the Liver: Part II. Redox Biology in Pathologic Hepatocytes and Implications for Intervention. Journal of Surgical Research 2011; 167(1): 96 doi: 10.1016/j.jss.2009.10.006
|
| 6 |
Ching-Hsuan Liu, Alagie Jassey, Hsin-Ya Hsu, Liang-Tzung Lin. Antiviral Activities of Silymarin and Derivatives. Molecules 2019; 24(8): 1552 doi: 10.3390/molecules24081552
|
| 7 |
Fernanda Caetano Camini, Camila Carla da Silva Caetano, Letícia Trindade Almeida, Cintia Lopes de Brito Magalhães. Implications of oxidative stress on viral pathogenesis. Archives of Virology 2017; 162(4): 907 doi: 10.1007/s00705-016-3187-y
|
| 8 |
|
| 9 |
Caecilia HC Sukowati, Korri E El-Khobar, Susan I Ie, Beatrice Anfuso, David H Muljono, Claudio Tiribelli. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(4): 1497-1512 doi: 10.3748/wjg.v22.i4.1497
|
| 10 |
Ruth Birk. Nutrigenetics of antioxidant enzymes and micronutrient needs in the context of viral infections. Nutrition Research Reviews 2021; 34(2): 174 doi: 10.1017/S0954422420000244
|
| 11 |
Jinah Choi. Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations. Free Radical Biology and Medicine 2012; 52(7): 1135 doi: 10.1016/j.freeradbiomed.2012.01.008
|
| 12 |
B. Kronenberger, S. Zeuzem, J. Bojunga. NASH und Hepatitis C. Der Gastroenterologe 2010; 5(2): 116 doi: 10.1007/s11377-009-0371-6
|
| 13 |
Cory Szybala, Mollie Parker Szybala, Peter B. Bongiorno. Textbook of Natural Medicine. 2020; : 1358 doi: 10.1016/B978-0-323-43044-9.00176-X
|
| 14 |
Goran Bjelakovic, Lise Lotte Gluud, Dimitrinka Nikolova, Marija Bjelakovic, Aleksandar Nagorni, Christian Gluud. Antioxidant supplements for liver diseases. Cochrane Database of Systematic Reviews 2011; doi: 10.1002/14651858.CD007749.pub2
|
| 15 |
Ashwani K. Singal, Sarat C. Jampana, Steven A. Weinman. Antioxidants as therapeutic agents for liver disease. Liver International 2011; 31(10): 1432 doi: 10.1111/j.1478-3231.2011.02604.x
|
| 16 |
Tom Luedde, Neil Kaplowitz, Robert F. Schwabe. Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance. Gastroenterology 2014; 147(4): 765 doi: 10.1053/j.gastro.2014.07.018
|
| 17 |
Bernd Schnabl. Peroxisome proliferator‐activated receptor‐δ as emerging target in liver disease. Drug Development Research 2010; 71(2): 106 doi: 10.1002/ddr.20358
|
| 18 |
Tommaso Iannitti, Beniamino Palmieri. Oxidative Stress in Vertebrates and Invertebrates. 2011; : 209 doi: 10.1002/9781118148143.ch15
|
| 19 |
Sophie Clément, Stéphanie Pascarella, Francesco Negro. Hepatitis C Virus Infection: Molecular Pathways to Steatosis, Insulin Resistance and Oxidative Stress. Viruses 2009; 1(2): 126 doi: 10.3390/v1020126
|
| 20 |
Kouichi Miura, Kojiro Taura, Yuzo Kodama, Bernd Schnabl, David A. Brenner. Hepatitis C virus–induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008; 48(5): 1420 doi: 10.1002/hep.22486
|
| 21 |
G. Bjelakovic, L. L. Gluud, D. Nikolova, M. Bjelakovic, A. Nagorni, C. Gluud. Meta‐analysis: antioxidant supplements for liver diseases – the Cochrane Hepato‐Biliary Group. Alimentary Pharmacology & Therapeutics 2010; 32(3): 356 doi: 10.1111/j.1365-2036.2010.04371.x
|
| 22 |
W. Halota, P. Ferenci, D. Kozielewicz, D. Dybowska, N. Lisovoder, S. Samira, I. Shalit, R. Ellis, Y. Ilan. Oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial. Journal of Viral Hepatitis 2015; 22(8): 651 doi: 10.1111/jvh.12369
|
| 23 |
Dina L Halegoua-De Marzio, Jonathan M Fenkel. Complementary and alternative medications in hepatitis C infection. World Journal of Hepatology 2014; 6(1): 9-16 doi: 10.4254/wjh.v6.i1.9
|
| 24 |
Sonia A. Lozano-Sepúlveda, Ana R. Rincón-Sanchez, Ana M. Rivas-Estilla. Antioxidants benefits in hepatitis C infection in the new DAAs era. Annals of Hepatology 2019; 18(3): 410 doi: 10.1016/j.aohep.2019.04.004
|
| 25 |
Peter Ferenci, Thomas–Matthias Scherzer, Heidrun Kerschner, Karoline Rutter, Sandra Beinhardt, Harald Hofer, Maximilian Schöniger–Hekele, Heidemarie Holzmann, Petra Steindl–Munda. Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy. Gastroenterology 2008; 135(5): 1561 doi: 10.1053/j.gastro.2008.07.072
|
| 26 |
Sonia A Lozano-Sepulveda, Owen L Bryan-Marrugo, Carlos Cordova-Fletes, Maria C Gutierrez-Ruiz, Ana M Rivas-Estilla. Oxidative stress modulation in hepatitis C virus infected cells. World Journal of Hepatology 2015; 7(29): 2880-2889 doi: 10.4254/wjh.v7.i29.2880
|
| 27 |
Natalia Dionisio, Maria V. Garcia-Mediavilla, Sonia Sanchez-Campos, Pedro L. Majano, Ignacio Benedicto, Juan A. Rosado, Gines M. Salido, Javier Gonzalez-Gallego. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. Journal of Hepatology 2009; 50(5): 872 doi: 10.1016/j.jhep.2008.12.026
|
| 28 |
Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada. Studies on Hepatic Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice 2015; : 389 doi: 10.1007/978-3-319-15539-5_18
|
| 29 |
Vali Musazadeh, Arash Karimi, Nasim bagheri, Jaber Jafarzadeh, Sarvin Sanaie, Mahdi Vajdi, Mozhde Karimi, Hamid Reza Niazkar. The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms. Biomedicine & Pharmacotherapy 2022; 154: 113593 doi: 10.1016/j.biopha.2022.113593
|
| 30 |
Carlos K. B. Ferrari, Paula C. S. Souto, Eduardo L. França, Adenilda C. Honorio-França. Oxidative and Nitrosative Stress on Phagocytes’ Function: from Effective Defense to Immunity Evasion Mechanisms. Archivum Immunologiae et Therapiae Experimentalis 2011; 59(6): 441 doi: 10.1007/s00005-011-0144-z
|
| 31 |
Nicholas A. Meanwell, John F. Kadow, Paul M. Scola. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry 2009; 44: 397 doi: 10.1016/S0065-7743(09)04420-0
|
| 32 |
Tuba Damar Çakırca, Mehmet Reşat Ceylan, İsmail Koyuncu, Gökhan Çakırca. Thiol‐disulphide balance and total oxidant‐antioxidant status in patients with chronic hepatitis C. International Journal of Clinical Practice 2021; 75(5) doi: 10.1111/ijcp.13988
|
| 33 |
Peter Ferenci. Silymarin in the treatment of liver diseases: What is the clinical evidence?. Clinical Liver Disease 2016; 7(1): 8 doi: 10.1002/cld.522
|
| 34 |
Elham Zarenezhad, Hussein T. Abdulabbas, Ahmed Shayaa Kareem, Seyed Amin Kouhpayeh, Silvia Barbaresi, Sohrab Najafipour, Abdulbaset Mazarzaei, Mitra Sotoudeh, Abdolmajid Ghasemian. Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review. Archives of Microbiology 2023; 205(6) doi: 10.1007/s00203-023-03590-0
|
| 35 |
|
| 36 |
Catherine Ulbricht, Ethan Basch, Wendy Chao, Julie Conquer, Dawn Costa, Samantha Culwell, Kelly Flanagan, Jackie Guilford, Paul Hammerness, Sadaf Hashmi, Richard Isaac, Erica Rusie, Jill M. Grimes Serrano, Christine Ulbricht, Mamta Vora, Regina C. Windsor, Matt Woloszyn, Sara Zhou. An Evidence-Based Systematic Review of Vitamin A by the Natural Standard Research Collaboration. Journal of Dietary Supplements 2012; 9(4): 299 doi: 10.3109/19390211.2012.736721
|
| 37 |
Melissa Palmer, Peter B. Bongiorno. Textbook of Natural Medicine. 2013; : 1409 doi: 10.1016/B978-1-4377-2333-5.00171-1
|
| 38 |
Rosario Gravier-Hernández, Lizette Gil-del Valle, Lindunka Valdes-Alonso, Nadiecha Hernández-Ayala, Yusimit Bermúdez-Alfonso, Daymé Hernández-Requejo, Teresa Rosell-Guerra, Maria C. Hernández-González-Abreu. Oxidative stress in hepatitis C virus–human immunodeficiency virus co-infected patients. Annals of Hepatology 2020; 19(1): 92 doi: 10.1016/j.aohep.2019.05.009
|